NewLink Genetics Surges 3% Following Ebola Contract News By: Benzinga via Benzinga December 22, 2014 at 09:32 AM EST NewLink Genetics Corp (NASDAQ: NLNK) and Merck & Co., Inc. (NYSE: MRK) on Monday announced a contract for development of an Ebola ... Read More >> Related Stocks: Merck & Co Newlink Genetics Cor